Stay updated on PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.

Latest updates to the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.3%
- Check8 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference4%
- Check15 days agoChange DetectedThe page has been updated to reflect a new version (v2.16.5) and a completion status, while previous information regarding the ClinicalTrials.gov data ingest and the status of a trial has been removed.SummaryDifference7%
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check51 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, and API users can provide input before this change. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
Stay in the know with updates to PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.